Overview of milling techniques for improving the solubility of poorly water-soluble drugs

被引:331
作者
Loh, Zhi Hui [1 ]
Samanta, Asim Kumar [2 ]
Heng, Paul Wan Sia [1 ]
机构
[1] Natl Univ Singapore, Dept Pharm, GEANUS Pharmaceut Proc Res Lab, Singapore 117543, Singapore
[2] Johnson & Johnson Ltd, Dept PDMS SMMD AD, Janssen India, Bombay 400080, Maharashtra, India
关键词
Drug solubility; Fluid energy milling; Ball milling; Media milling; High pressure homogenization; Cryomilling; HIGH-PRESSURE HOMOGENIZATION; PARTICLE-SIZE REDUCTION; VITAMIN-E TPGS; VITRO-IN-VIVO; PHYSICAL STABILITY; DISSOLUTION RATE; LASER DIFFRACTION; AMORPHOUS PHASE; ORAL BIOAVAILABILITY; LIPID NANOPARTICLES;
D O I
10.1016/j.ajps.2014.12.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Milling involves the application of mechanical energy to physically break down coarse particles to finer ones and is regarded as a "top-down" approach in the production of fine particles. Fine drug particulates are especially desired in formulations designed for parenteral, respiratory and transdermal use. Most drugs after crystallization may have to be comminuted and this physical transformation is required to various extents, often to enhance processability or solubility especially for drugs with limited aqueous solubility. The mechanisms by which milling enhances drug dissolution and solubility include alterations in the size, specific surface area and shape of the drug particles as well as milling-induced amorphization and/or structural disordering of the drug crystal (mechanochemical activation). Technology advancements in milling now enable the production of drug micro-and nano-particles on a commercial scale with relative ease. This review will provide a background on milling followed by the introduction of common milling techniques employed for the micronization and nanonization of drugs. Salient information contained in the cited examples are further extracted and summarized for ease of reference by researchers keen on employing these techniques for drug solubility and bioavailability enhancement. (c) 2015 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:255 / 274
页数:20
相关论文
共 159 条
[1]   Effect of Cryogrinding on Chemical Stability of the Sparingly Water-Soluble Drug Furosemide [J].
Adrjanowicz, Karolina ;
Kaminski, Kamil ;
Grzybowska, Katarzyna ;
Hawelek, Lukasz ;
Paluch, Marian ;
Gruszka, Irena ;
Zakowiecki, Daniel ;
Sawicki, Wieslaw ;
Lepek, Przemyslaw ;
Kamysz, Wojciech ;
Guzik, Lukasz .
PHARMACEUTICAL RESEARCH, 2011, 28 (12) :3220-3236
[2]   Image analysis of the shape of granulated powder grains [J].
Almeida-Prieto, S ;
Blanco-Méndez, J ;
Otero-Espinar, FJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (03) :621-634
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]   Development of a New Method to Assess Nanocrystal Dissolution Based on Light Scattering [J].
Anhalt, Katharina ;
Geissler, Simon ;
Harms, Meike ;
Weigandt, Markus ;
Fricker, Gert .
PHARMACEUTICAL RESEARCH, 2012, 29 (10) :2887-2901
[5]  
[Anonymous], 1897, J. Am. Chem. Soc., DOI [DOI 10.1021/JA02086A003, 10.1021/ja02086a003]
[6]   Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats [J].
Anwar, Mohammed ;
Warsi, Musarrat H. ;
Mallick, Neha ;
Akhter, Sohail ;
Gahoi, Sachin ;
Jain, Gaurav K. ;
Talegaonkar, Sushma ;
Ahmad, Farhan J. ;
Khar, Roop K. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 (03) :241-249
[7]  
Ashford M., 2002, Pharmaceutics: The Science of Dosage Form Design, P253
[8]  
Aulton M., 2002, Pharmaceutics: The Science of Dosage form Design, V2nd, P15
[9]   Amorphization of indomethacin by co-grinding with neusilin US2: Amorphization kinetics, physical stability and mechanism [J].
Bahl, Deepak ;
Bogner, Robin H. .
PHARMACEUTICAL RESEARCH, 2006, 23 (10) :2317-2325
[10]   Influence of Excipients in Comilling on Mitigating Milling-Induced Amorphization or Structural Disorder of Crystalline Pharmaceutical Actives [J].
Balani, Prashant N. ;
Ng, Wai Kiong ;
Tan, Reginald B. H. ;
Chan, Sui Yung .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (05) :2462-2474